Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.05% vs 4.36% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 306.14% vs -44.99% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 85.51% vs -21.01% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 20.00% vs -6.25% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Sapporo Clinical Laboratory, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.05% vs 4.36% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 3.47% vs 1.17% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 306.14% vs -44.99% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 24.38% vs -23.97% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 85.51% vs -21.01% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 23.56% vs 8.05% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 20.00% vs -6.25% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.88% vs -10.53% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






